We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
This release summarises the diagnoses in 2021 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)
One and 3- year unadjusted and case-mix adjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator nationally and at sub–Integrated Care Board (sub-ICB) level.
Cancer registration statistics produced by the UK Health Security Agency (UKHSA).
Estimated proportion of all malignant cancers where patients first presented as an emergency.
See how cancer rates have been changing.
Cancer survival statistics for adults and children by stage at diagnosis and by different geographical variations.
Information on the programme, including commissioning, quality assurance, education and training.
One-year cancer survival for all-cancers combined; for breast, colorectal and lung cancer separately; and for these three cancers combined.
One-year cancer survival by Clinical Commissioning Group for all-cancers combined, 3 cancers combined, breast, colorectal and lung.
Guidance on the role of breast screening and symptomatic services in identifying interval cancer and giving results to patients.
This letter from Professor Sir Mike Richards, National Cancer Director, highlights plans to introduce General Practice Profiles for cancer
This article presents new 5-year cancer survival estimates by stage and outlines how stage of diagnosis for different cancers affects health outcomes.
Lead and co-ordinate PHE’s cancer-related work to support the Independent Cancer Taskforce recommendations to prevent and beat cancer.
Reports on the impact of some common cancers on the health of people in the South East of England.
Incidence and survival for a range of cancer types in NI during 1993-2020 with time trends, patient and tumour characteristics and geographic variations in incidence included.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).